JWH 073 N-(4-hydroxybutyl) β-D-Glucuronide – 1 mg

Brand:
Cayman
CAS:
1322008-41-2
Storage:
-20
UN-No:
Non-Hazardous - /

JWH 073 (Item No. 14237) is a mildly selective agonist of the central cannabinoid (CB1) receptor derived from the aminoalkylindole WIN 55,212-2. The Ki values for binding CB1 and the peripheral CB2 receptor are 8.9 and 38 nM, respectively, for a CB1:CB2 ratio of 0.23.{16797} JWH 073 is one of several synthetic CBs which have been included in smoking mixtures. JWH 073 N-(4-hydroxybutyl) β-D-Glucuronide is expected to be a urinary metabolite of JWH 073 based on the metabolism of the closely-related JWH 015 (Item No. 10009018) and JWH 018 (Item No. 10900).{18291,19353,20170} The physiological and toxicological properties of this compound have not been tested. This product is intended for forensic and research applications.  

 

Available on backorder

SKU: 11464 - 1 mg Category:

Description

Expected urinary metabolite of JWH 073


Formal name: 4-[3-(1-naphthalenylcarbonyl)-1H-indol-1-yl]butyl β-D-glucopyranosiduronic acid

Synonyms: 

Molecular weight: 519.6

CAS: 1322008-41-2

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Drugs of Abuse||Research Area|Forensic Chemistry & Toxicology|Cannabinoids|Synthetic Cannabinoids